During the first waves of the coronavirus disease 2019 (COVID-19) pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, olfactory …

The administration of vaccination doses to the global population has led to a decrease in the
incidence of COVID-19. However, the clinical picture developed by infected individuals …

Background Since the emergence of the COVID-19 infection in China, it has caused
considerable morbidity, mortality, and economic burden. It causes the vast majority of clinical …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells by binding
to the angiotensin-converting enzyme 2 (hACE2) receptor. This process is aided by the …

The contribution of human genes to the variability of disease outcomes has been shown to
be important across infectious diseases. Studies have shown mutations within specific …

Abstract Transmembrane protease/serine (TMPRSS2), a type II transmembrane serine
protease, plays a crucial role in different stages of cancer. Recent studies have reported that …

Since the COVID-19 pandemic, the diversity of clinical manifestations in patients has been a
tremendous challenge. It seems that genetic variations, as one of the players, contribute to …

Introduction The COVID-19 pandemic represented one of the most significant challenges to
researchers and healthcare providers. Several factors determine the disease severity …

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly
impacted global healthcare systems and spurred extensive research efforts over the past …

Abstract Background The World Health Organization (WHO) declared Coronavirus Disease
2019 (COVID-19) a global pandemic on March 11, 2020. Severe Acute Respiratory …